This report focuses on the global Tuberculosis (TB) Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tuberculosis (TB) Diagnostics development in United States, Europe and China. Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The increasing number of government and non-government initiatives to eradicate tuberculosis (TB) is expected to be one of the primary drivers for the global tuberculosis (TB) diagnostics market growth till 2023. A global TB control program was introduced by the US Agency for International Development (USAID) in the year 1998. To support the eradication of TB, the US prioritized and provided increased funding for bilateral and multilateral programs in the subsequent decades. Similarly, the division of?tuberculosis?elimination (DTBE), adopted strategic plans to control TB in the US. These programs reduce the incidence and mortality by 50%. The increasing prevalence of TB and rising population in APAC is driving the growth prospects for the global tuberculosis (TB) diagnostics market in the region. The governments in the region are motivated to take measures to improve the healthcare infrastructure. They are also extensively focusing on the preventive care due to the rising population, especially in China and India. Furthermore, the enhancement of healthcare infrastructure in countries such as Singapore, Japan, Australia, and South Korea will boost the adoption of tuberculosis diagnostics in the APAC region. In 2017, the global Tuberculosis (TB) Diagnostics market size was 2040 million US$ and it is expected to reach 2770 million US$ by the end of 2025, with a CAGR of 3.9% during 2018-2025. The key players covered in this study Abbott BD bioM?rieux F. Hoffmann-La Roche Thermo Fisher Scientific ... Market segment by Type, the product can be split into Smear Microscopy Molecular Testing Mantoux Tuberculin Test Culture Drug Susceptibility Testing LF-LAM for PLHIV Market segment by Application, split into Diagnostic Laboratories Hospitals Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Tuberculosis (TB) Diagnostics status, future forecast, growth opportunity, key market and key players. To present the Tuberculosis (TB) Diagnostics development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Tuberculosis (TB) Diagnostics are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type (2013-2025) 1.4.2 Smear Microscopy 1.4.3 Molecular Testing 1.4.4 Mantoux Tuberculin Test 1.4.5 Culture 1.4.6 Drug Susceptibi
